Kidney cancer PDOXs reveal patient‐specific pro‐malignant effects of antiangiogenics and its molecular traits
Abstract An open debate in antiangiogenic therapies is about their consequence on tumor invasiveness and metastasis, which is undoubtedly relevant for patients currently treated with antiangiogenics, such as renal cell carcinoma patients. To address, this we developed an extensive series of 27 patie...
Saved in:
| Main Authors: | Lidia Moserle, Roser Pons, Mar Martínez‐Lozano, Gabriela A Jiménez‐Valerio, August Vidal, Cristina Suárez, Enrique Trilla, José Jiménez, Inés de Torres, Joan Carles, Jordi Senserrich, Susana Aguilar, Luis Palomero, Alberto Amadori, Oriol Casanovas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2020-11-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201911889 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Natural products‐based antiangiogenic agents: New frontiers in cancer therapy
by: Tiago Azevedo, et al.
Published: (2024-11-01) -
MATHEMATICS MODEL OF COMPACT TUMOR TO ANALYZE THE EFFECT ANTIANGIOGENIC THERAPY
by: Eristia Arfi, et al.
Published: (2024-07-01) -
Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
by: D. V. Garbuzenko
Published: (2018-11-01) -
New approach to modeling of antiangiogenic treatment on the basis of Hahnfeldt et al. model
by: Jan Poleszczuk, et al.
Published: (2011-03-01) -
MODERN IDEAS ABOUT THE COMBINATION OF RADIATION THERAPY WITH ANTIANGIOGENIC DRUGS IN THE TREATMENT OF PATIENTS WITH BRAIN METASTASES
by: O. I. Kit, et al.
Published: (2020-03-01)